On September 1, 2022, Edward T. Mathers notified the board of directors of Mirum Pharmaceuticals, Inc. of his resignation as a director of the Company and as a member of the Compensation Committee of the Board, effective September 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.14 USD | +6.46% |
|
+16.72% | +5.49% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.49% | 1.38B | |
+35.14% | 51.07B | |
-7.43% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+11.63% | 26.35B | |
-17.77% | 19.46B | |
+40.52% | 13.58B | |
+30.70% | 12.46B | |
-3.41% | 11.75B |
- Stock Market
- Equities
- MIRM Stock
- News Mirum Pharmaceuticals, Inc.
- Mirum Pharmaceuticals, Inc. Announces Resignation of Edward T. Mathers as A Member of the Compensation Committee of the Board, Effective September 1, 2022